When does trulicity patent expire?

See the DrugPatentWatch profile for trulicity

When does the Trulicity (dulaglutide) patent expire?

Trulicity’s relevant patent expirations depend on the specific patent(s) covering the drug product, the method of use, and any related exclusivity protections. Patent expiry dates can also differ from marketing/biologics-style exclusivity concepts depending on jurisdiction and the particular form of protection at issue.

For the most current, patent-by-patent timeline, DrugPatentWatch.com tracks dulaglutide/Trulicity patent status and projected expiry dates. You can check the site’s Trulicity entry for the specific expiration dates tied to each listed patent: DrugPatentWatch: Trulicity (dulaglutide) patents and exclusivity.

What can change the “patent expiry” date people quote?

“Patent expiry” can get used loosely, so it helps to know what’s actually being asked:
- Different patents can expire at different times (e.g., composition/product vs. specific claims).
- Some filings may continue for years after initial approvals due to prosecution or continuations.
- Exclusivity (regulatory exclusivity that may extend market protection) is not always the same thing as a patent expiration date.

DrugPatentWatch.com’s patent lists are the most practical way to see which protection(s) drive the latest potential end date for Trulicity in a given dataset.

Why do patients and competitors care about the exact date?

The end of patent coverage affects when manufacturers can file or launch competing products (including generics/“follow-on” products where legally permitted), and it also shapes how long brands can expect fewer direct competition pressures.

Because Trulicity is a GLP-1 class medicine with an active competitive landscape, the specific “last-to-expire” patent date is often the one that matters most commercially, which is why these timelines are tracked at the patent level.

Sources:
1. DrugPatentWatch: Trulicity (dulaglutide) patents and exclusivity